Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease

OBJECTIVES: Ferumoxytol is an alternative to gadolinium-based compounds as a vascular contrast agent for magnetic resonance angiography (MRA), particularly for patients with chronic kidney disease (CKD). However, dose-related efficacy data are lacking. We aimed to determine the optimal (minimum effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoumpos, Sokratis, Hennessy, Martin, Vesey, Alex T., Radjenovic, Aleksandra, Kasthuri, Ram, Kingsmore, David B., Mark, Patrick B., Roditi, Giles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Magnetic Resonance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554242/
https://www.ncbi.nlm.nih.gov/pubmed/30919067
http://dx.doi.org/10.1007/s00330-019-06137-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554242/
https://www.ncbi.nlm.nih.gov/pubmed/30919067
http://dx.doi.org/10.1007/s00330-019-06137-4

Ejemplares similares